12:00 AM
Jul 02, 2012
 |  BC Week In Review  |  Company News  |  Other News

Roche pharmaceuticals news

Roche is closing its R&D site in Nutley, N.J., and cutting about 1,000 positions as part of a restructuring of its Pharma Research and Early Development division. The site's activities, which include projects in inflammation, cancer and virology, will be consolidated at its sites in Switzerland and Germany by the end of 2013. Division Head Jean-Jacques Garaud will depart, effective June 30. Mike Burgess, global head of oncology and large molecule research, will take over as acting head of the division. After the restructuring, the division...

Read the full 406 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >